Researchers have discovered a protein which is critical for steering melanoma cancer cells as they spread throughout the body ...

Appendix cancer is a disease in which cancerous cells form in the tissues of the appendix. There are many forms of appendix cancer. Some forms of cancer involve the cells lining the inside of the ...

Background: In patients with metastatic midgut carcinoid tumors increased serotonin secretion is related to the carcinoid syndrome and mortality. Free serotonin is taken up via the serotonin ...

For adults with tumors, the effect of the medication on tumor size, growth rate and metastases development have not been determined, according to the release. “With today’s launch of ...

Long-term treatment of the severe diarrhea and flushing episodes associated with metastatic carcinoid tumors. [Read more: Teva obtains FDA nod for generic Forteo] ...

The first generic version of Sandostatin ® LAR Depot is now available from Teva Pharmaceuticals. Teva’s Octreotide Acetate for Injectable Suspension is indicated for treatment in patients who ...

Purpose Metastatic carcinoid is an incurable malignancy whose symptoms, such as diarrhea and flushing, can be debilitating and occasionally life-threatening. Although symptom relief is available with ...

The study, recently published in Nature Genetics, uncovers notable differences between primary and metastatic pancreatic cancer, which could lead to new treatment strategies for the often-deadly ...

It involved patients with metastatic or locally advanced grade 1/2 carcinoid tumors (n = 20) or pancreatic NETs (n = 32).

However, some patients experience aggressive growth and spread (metastasis) of the tumor with poor chances of recovery. The biological causes of these different forms of the disease are still unknown.

DNA secreted by tumor cell extracellular vesicles prompts anti-metastatic immune response Date: December 3, 2024 Source: Weill Cornell Medicine Summary: Specially packaged DNA secreted by tumor ...

A Phase III study of pasireotide LAR versus octreotide LAR is ongoing in patients with metastatic carcinoid tumors (GI-NETs) whose disease-related symptoms are inadequately controlled by ...